Bibliography

The following is not a comprehensive list of published works by GIRC Thrombose - France members. If you know of other published works authored by members, please do not hesitate to tell us about them.

2012

• Büller HR, Gallus AS, Pillion G, Prins MH, Raskob GE; Cassiopea Investigators. Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trial. Lancet. 2012 Jan 14;379(9811):123-9. 22130488

• Bertoletti L, Mismetti P, Decousus H.The cloud of pulmonary embolism during COPD exacerbation.Thorax. 2012 Feb;67(2):177-8; author reply 178. Epub 2011 Jun 18.

• Le Duc-Pennec A, Le Roux PY, Cornily JC, Jaffrelot M, Delluc A, de Saint-Martin L, Guillo P, Le Gal G, Salaun PY, Leroyer C.Diagnostic accuracy of single-photon emission tomography ventilation/perfusion lung scan in the diagnosis of pulmonary embolism.Chest. 2012 Feb;141(2):381-7. Epub 2011 Aug 18.

• EINSTEIN–PE Investigators, Büller HR, Prins MH, Lensin AW, Decousus H, Jacobson BF, Minar E, Chlumsky J, Verhamme P, Wells P, Agnelli G, Cohen A, Berkowitz SD, Bounameaux H, Davidson BL, Misselwitz F, Gallus AS, Raskob GE, Schellong S, Segers A. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med. 2012 Apr 5;366(14):1287-97. 22449293

• Galanaud JP, Bosson JL, Genty C, Presles E, Cucherat M, Sevestre MA, Quere I, Decousus H, Leizorovicz A. Superficial vein thrombosis and recurrent venous thromboembolism: a pooled analysis of two observational studies. J Thromb Haemost. 2012 Mar19.doi:10.1111/j.1538-7836.2012.04704.x. 22429908

2011

• Decousus H, Tapson VF, Bergmann JF, Chong BH, Froehlich JB, Kakkar AK, Merli GJ, Monreal M, Nakamura M, Pavanello R, Pini M, Piovella F, Spencer FA, Spyropoulos AC, Turpie AG, Zotz RB, Fitzgerald G, Anderson FA; IMPROVE Investigators. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest. 2011 Jan;139(1):69-79. Epub 2010 May 7.

• Bertoletti L, Righini M, Bounameaux H, López-Jiménez L, Tiraferri E, Visonà A, Monreal M; the RIETE Investigators; Acute venous thromboembolism after non-major orthopaedic surgery or post-traumatic limb immobilisation. Findings from the RIETE registry; Thromb Haemost. 2011 Apr;105(4):739-41. Epub 2011 Jan 12.

• Décousus H, Bertoletti L, Frappé P, Becker F, Jaouhari AE, Mismetti P, Moulin N, Presles E, Quéré I, Leizorovicz A.Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis.Thromb Res. 2011 Feb;127 Suppl 3:S81-5.

• Galanaud JP, Genty C, Sevestre MA, Brisot D, Lausecker M, Gillet JL, Rolland C, Righini M, Leftheriotis G, Bosson JL, Quere I; OPTIMEV SFMV investigators.Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study.Thromb Haemost. 2011 Jan;105(1):31-9. Epub 2010 Sep 30.

• LE Gal G, Carrier M, Kovacs MJ, Betancourt MT, Kahn SR, Wells PS, Anderson DA, Chagnon I, Solymoss S, Crowther M, Righini M, Delluc A, White RH, Vickars L, Rodger M.Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: data from the REVERSE cohort study.J Thromb Haemost. 2011 Jun;9(6):1126-32. doi: 10.1111/j.1538-7836.2011.04240.x.

• Carrier M, Rodger MA, Wells PS, Righini M, LE Gal G.Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: a systematic review and meta-analysis.J Thromb Haemost. 2011 Jun;9(6):1119-25. doi: 10.1111/j.1538-7836.2011.04254.x.

• Spyropoulos AC, Anderson FA Jr, Fitzgerald G, Decousus H, Pini M, Chong BH, Zotz RB, Bergmann JF, Tapson V, Froehlich JB, Monreal M, Merli GJ, Pavanello R, Turpie AG, Nakamura M, Piovella F, Kakkar AK, Spencer FA; IMPROVE Investigators.Predictive and associative models to identify hospitalized medical patients at risk for VTE.Chest. 2011 Sep;140(3):706-14. Epub 2011 Mar 24.

• Bertoletti L, Le Gal G, Aujesky D, Roy PM, Sanchez O, Verschuren F, Bounameaux H, Perrier A, Righini M.Prognostic value of the Geneva prediction rule in patients in whom pulmonary embolism is ruled out.J Intern Med. 2011 Apr;269(4):433-40. doi: 10.1111/j.1365-2796.2010.02328.x. Epub 2010 Dec 28.

• Delluc A, Le Moigne E, Tromeur C, Noel-Savina E, Couturaud F, Mottier D, Le Gal G, Lacut K.Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.Br J Haematol. 2011 Aug;154(4):486-91. doi: 10.1111/j.1365-2141.2011.08592.x. Epub 2011 Jun 14.

• Falvo N, Bonithon-Kopp C, Rivron Guillot K, Todoli JA, Jiménez-Gil M, Di Micco P, Monreal M; RIETE Investigators.Heparin-associated thrombocytopenia in 24,401 patients with venous thromboembolism: findings from the RIETE Registry.J Thromb Haemost. 2011 Sep;9(9):1761-8. doi: 10.1111/j.1538-7836.2011.04402.x.

• Aujesky D, Roy PM, Verschuren F, Righini M, Osterwalder J, Egloff M, Renaud B, Verhamme P, Stone RA, Legall C, Sanchez O, Pugh NA, N'gako A, Cornuz J, Hugli O, Beer HJ, Perrier A, Fine MJ, Yealy DM.Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial.Lancet. 2011 Jul 2;378(9785):41-8. Epub 2011 Jun 22.

• Parent F, Bachir D, Inamo J, Lionnet F, Driss F, Loko G, Habibi A, Bennani S, Savale L, Adnot S, Maitre B, Yaïci A, Hajji L, O'Callaghan DS, Clerson P, Girot R, Galacteros F, Simonneau G.A hemodynamic study of pulmonary hypertension in sickle cell disease.N Engl J Med. 2011 Jul 7;365(1):44-53.

• Mueck W, Lensing AW, Agnelli G, Decousus H, Prandoni P, Misselwitz F.Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.Clin Pharmacokinet. 2011 Oct;50(10):675-86. doi: 10.2165/11595320-000000000-00000.

• Gris JC, Bouvier S, Molinari N, Galanaud JP, Cochery-Nouvellon E, Mercier E, Fabbro-Peray P, Balducchi JP, Marès P, Quéré I, Dauzat M. Comparative incidence of a first thrombotic event in purely obstetric antiphospholipid syndrome with pregnancy loss: the NOH-APS observational study. Blood. 2011 Dec 6: 22147897

• Kakkar AK, Cimminiello C, Goldhaber SZ, Parakh R, Wang C, Bergmann JF; LIFENOX Investigators. Low-molecular-weight heparin and mortality in acutely ill medical patients. N Engl J Med. 2011 Dec 29;365 (26):2463-72. PMID: 22204723

• Germain M, Saut N, Greliche N, Dina C, Lambert JC, Perret C, Cohen W, Oudot-Mellakh T, Antoni G, Alessi MC, Zelenika D, Cambien F, Tiret L, Bertrand M, Dupuy AM, Letenneur L, Lathrop M, Emmerich J, Amouyel P, Trégouët DA, Morange PE. Genetics of venous thrombosis: insights from a new genome wide association study. PLoS One. 2011;6(9):e25581.PMID: 21980494

• Galanaud JP, Genty C, Sevestre MA, Brisot D, Lausecker M, Gillet JL, Rolland C, Righini M, Leftheriotis G, Bosson JL, Quere I; OPTIMEV SFMV investigators. Predictive factors for concurrent deep-vein thrombosis and symptomatic venous thromboembolic recurrence in case of superficial venous thrombosis. The OPTIMEV study. Thromb Haemost. 2011 Jan 3;105(1):31-9. Epub 2010 Sep 30.

2010

• Decousus H, Quéré I, Presles E, Becker F, Barrellier MT, Chanut M, Gillet JL, Guenneguez H, Leandri C, Mismetti P, Pichot O, Leizorovicz A, for the POST Study Group. Superficial thrombophlebitis and venous thromboembolism: A large prospective epidemiological study. Annals Intern Med 2010. 152(4):218-24.

• Galanaud JP, Cochery-Nouvellon E, Alonso S, Chauleur C, Mercier E, Lissalde-Lavigne G, Fabbro-Peray P, Reny JL, Mares P, Dauzat M, Quéré I, Gris JC. Paternal endothelial protein C receptor 219Gly variant as a mild and limited risk factor for deep-vein thrombosis during pregnancy. J Thromb Haemost 2010; 8(4): 707-13.

• Meyer G, Roy PM, Gilberg S, Perrier A. Pulmonary embolism. BMJ. 2010 Apr 13;340:c1421. doi: 10.1136/bmj.c1421.

• Decousus H, Prandoni P, Mismetti P, Bauersachs R, Boda Z, Brenner B, Laporte S, Matyas L, Middeldorp S, Sokurenko G and Leizorovicz A for the Calisto Study Group. Fondaparinux in the treatment of superficial-vein thrombosis of the leg. N Eng J Med 2010 ;363: 1222-32.

• EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010 Dec 23;363(26):2499-510. Epub 2010 Dec 3.

2009

• Quere I, Righini M. Ultrasound-based diagnostic strategies for deep vein thrombosis. JAMA. 2009 Mar 4;301(9):933; author reply 934-935.

• Roy PM, Durieux P, Gillaizeau F, Legall C, Armand-Perroux A, Martino L, Hachelaf M, Dubart AE, Schmidt J, Cristiano M, Chretien JM, Perrier A, Meyer G. A computerized handheld decision-support system to improve pulmonary embolism diagnosis: a randomized trial. Ann Intern Med. 2009 Nov 17;151(10):677-86.

• Roy PM. Diagnosis of venous thromboembolism. BMJ. 2009 Aug 19;339:b2799. doi: 10.1136/bmj.b2799.
  

2008

• Debourdeau P, Farge-Bancel D, Bosquet L, Kassab-Chahmi D, Cajfinger F, Desmurs-Clavel H, Desruennes E, Douard MC, Elias A, Elalamy I, Grange C, Hocini H, Kriegel I, Le Gal G, Levesque H, Mahé I, Meyer G, Mismetti P, Pavic M, Quéré I, Renaudin JM, Scrobohaci ML. 2008 Standards, Options: recommandations for venous thromboembolic events (VTE) treatment and central venous catheter thrombosis (CVCT) management in cancer patients. Bull Cancer. 2008; 95 : 750-61

• Laporte S, Mismetti P, Decousus H, Uresandi F, Otero R, Lobo JL, Monreal M and the RIETE Investigators. Predictive factors for fatal pulmonary embolism in 15 520 patients with venous thromboembolism. Findings from the RIETE registry. Circulation 2008; 117:1711-6

• Righini M, Le Gal G, Aujesky D, .Roy PM, Sanchez O, Verschuren F, Rutschmann O, Nonent M, Cornuz J, Thys F, Le Manach CP, Revel MP, Poletti PA, Meyer G, Mottier D, Perneger T, Bounameaux H, Perrier A. Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography of the leg: a randomised non-inferiority trial. Lancet 2008; 371: 1343 : 52

2007

• Buller HR, Cohen A, Davidson B, Decousus H, Gallus AS, Gent M, Pillion F, Piovella F, Prins MH, Raskob GE for the Van Gogh Investigators. Evaluation of once weekly subcutaneous idraparinux versus standard therapy with heparin and vitamin K antagonists in the treatment of deep-vein thrombosis or pulmonary embolism. N Engl J Med 2007, 357 :1094-104

• Buller HR, Cohen A, Davidson B, Decousus H, Gallus AS, Gent M, Pillion F, Piovella F, Prins MH, Raskob GE for the Van Gogh Investigators. Extended prophylaxis of venous thromboembolism with Idraparinux. N Engl J Med 2007, 357 :1105-1112
  

2005

• The PREPIC Study Group. Decousus H Chairman. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: The PREPIC randomized study. Circulation 2005; 112 : 416-22

2004

• Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators. Fondaparinux or Enoxaparin for the initial treatment of symptomatic deep-vein thombosis : a randomised, double-blind non-inferiority trial. Ann Intern Med 2004; 140 : 867-73

2003

• Buller HR, Davidson BL, Decousus H, Gallus A, Gent M, Piovella F, Prins MH, Raskob G, van den Berg-Segers AE, Cariou R, Leeuwenkamp O, Lensing AW; Matisse Investigators. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003; 349:1695-702

• The STENOX Study Group. Decousus H chairman. A pilot randomized double-blind comparison of low-molecular-weight heparin, a non-steroidal anti inflammatory agent, and placebo in the treatment of superficial-vein thrombosis. Arch Intern Med 2003; 163 : 1657-1663

1998

• Decousus H, Leizorovicz A, Parent F, Page Y, Tardy B, Girard Ph, Laporte S, Faivre R, Charbonnier B, Barral FG, Huet Y, Simonneau G, for the PREPIC Study Group. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis. N Engl J Med 1998 ; 338 : 409-415